Global Non-Steroidal Anti Inflammatory Drugs Market Size, Trends & Growth Opportunity, By Type (Ibuprofen, Aspirin, Naproxen, Nabumetone, and Others), By Application (Back Pain Treatment, Osteoarthritis Treatment, and Others), By Region and Forecast till 2027.
Global Non-Steroidal Anti Inflammatory Drugs Market 
The Global Non-Steroidal Anti Inflammatory Drugs Market is expected to grow from US$ 15.58 Billion in 2021 to US$ 24.35 Billion by 2027; it is estimated to grow at a CAGR of 7.72% from 2022 to 2027.

Market Overview

The class of analgesics known as non-steroidal anti-inflammatory drugs is differentiated by their non-steroidal chemical structure. These are employed to lessen discomfort brought on by inflammation. Due to their unique properties, including antipyretic, analgesic, and anti-inflammatory effects, it is the first line of therapy for pain management.

Market Drivers

The primary factor anticipated to fuel the growth of the global market for non-steroidal anti-inflammatory drugs is the rise in bone and joint pain disorders among people, including osteoarthritis and rheumatoid arthritis. Additionally, the increase in surgical procedures will benefit market expansion. Additionally, the market will expand due to the rising geriatric population and high risk of contracting different diseases. Additionally, the market development during this forecast period will be driven by end users' adoption of pain management therapeutics.
 
Market Restraints

The primary restraint on the development of the global market for non-steroidal anti-inflammatory drugs is anticipated to be the availability of novel, innovative therapeutic analgesics. Additionally, strict government laws and restrictions will hinder market expansion.

Market Opportunities

A rise in the quantity of R&D activities is another factor driving the market's expansion. The market for topical non-steroidal anti-inflammatory drugs will benefit from these possibilities. Along with this, an increase in medication launches and approvals will speed up the market's expansion.

Impact of Covid-19

Nearly every industry was impacted by the unprecedented global public health emergency known as COVID-19, and the long-term effects are expected to have an influence on the expansion of a number of end-use industries over the course of the forecast period. In order to guarantee the inclusion of underlying COVID-19 issues and potential future directions, this ongoing study expands the research framework. In-depth analysis of the effects of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake is revealed in the report's devoted section, which also offers suggestions for long-term solutions. The updated research offers information, analysis, projections, and forecasts taking into account the effect of COVID-19 on the global market for non-steroidal anti-inflammatory drugs.

Market Segmentation

Global Non-Steroidal Anti Inflammatory Drugs Market is segmented into type such as Ibuprofen, Aspirin, Naproxen, Nabumetone, and Others. Further, market is segmented into application such as Back Pain Treatment, Osteoarthritis Treatment, and Others.
Also, Global Non-Steroidal Anti Inflammatory Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as GlaxoSmithKline, Johnson and Johnson, Pfizer Inc, Kopran Ltd, Bayer (DE), Abbott, Novacap (FR), Perrigo Company, and Sun Pharmaceutical Industries Ltd.

Industrial Development

• The US Food and Drug Administration (FDA) authorised the painkiller Zynrelef (extended-release dual-acting local anaesthesia of bupivacaine and meloxicam) in May 2021, according to Heron Therapeutics, Inc.

• The US Food & Drug Administration granted Strides Pharma Science Limited permission to market Ibuprofen Oral Suspension in February 2021. (USFDA).

Market Taxonomy

By Type
• Ibuprofen
• Aspirin
• Naproxen
• Nabumetone
• Others

By Application
• Back Pain Treatment
• Osteoarthritis Treatment
• Others

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report
• What are the Key Opportunities in Global Non-Steroidal Anti Inflammatory Drugs Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Global Non-Steroidal Anti Inflammatory Drugs Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Non-Steroidal Anti Inflammatory Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Non-Steroidal Anti Inflammatory Drugs Market, By Type
5.1 Y-o-Y Growth Comparison, By Type 
5.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type 
5.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Type
5.3.1 Ibuprofen
5.3.2 Aspirin
5.3.3Naproxen
5.3.4Nabumetone
5.3.5 Others
6 Global Non-Steroidal Anti Inflammatory Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Application
6.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
6.3.1 Back Pain Treatment
6.3.2 Osteoarthritis Treatment
6.3.3Others
7 Global Non-Steroidal Anti Inflammatory Drugs Market, By Region
7.1 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Region
7.2 Global Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Region
7.3 Global Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Region
8 North America Non-Steroidal Anti Inflammatory Drugs Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type
8.3 North America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application
8.4 North America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe Non-Steroidal Anti Inflammatory Drugs Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type 
9.3 Europe Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application 
9.4 Europe Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type 
10.3 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application 
10.4 Asia Pacific Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Non-Steroidal Anti Inflammatory Drugs Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type 
11.3 Latin America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application 
11.4 Latin America Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
12 Middle East Non-Steroidal Anti Inflammatory Drugs Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Non-Steroidal Anti Inflammatory Drugs Market Share Analysis, By Type 
12.3 Middle East Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Application 
12.4 Middle East Non-Steroidal Anti Inflammatory Drugs Market Size and Forecast, By Country
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 GlaxoSmithKline
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Johnson and Johnson
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Pfizer Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Kopran Ltd
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Bayer (DE)
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Abbott
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Novacap (FR)
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Perrigo Company
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Sun Pharmaceutical Industries Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies